Rapid detection of Mycobacterium tuberculosis and rifampin-resistance using on-demand, near patient technology. Journal of clinical microbiology [J Clin Microbiol] Journal article | | Title | Rapid detection of Mycobacterium tuberculosis and rifampin-resistance using on-demand, near patient technology. | | Author(s) | Helb D, Jones M, Story E, Boehme C, Wallace E, Ho K, Kop J, Owens MR, Rodgers R, Banada P, Safi H, Blakemore R, Lan NT, Jones-López EC, Levi M, Burday M, Ayakaka I, Mugerwa RD, McMillan B, Winn-Deen E, Christel L, Dailey P, Perkins MD, Persing DH, Alland D | | Institution | Department of Medicine, New Jersey Medical School - UMDNJ, Newark, NJ; Cepheid, Sunnyvale, CA; Foundation for Innovative New Diagnostics, Geneva, Switzerland; Pham Ngoc Thach Hospital, Ho Chi Minh City, Vietnam; Montefiore Medical Center, Bronx, NY; Department of Pathology, New Jersey Medical School - UMDNJ, Newark, NJ; Makerere University - UMDNJ Research Collaboration, Kampala, Uganda; Department of Medicine, Makerere University School of Medicine, Kampala, Uganda. | | Source | J Clin Microbiol 2009 Oct 28. | | Abstract | Current nucleic acid amplification methods to detect Mycobacterium tuberculosis are complex, labor-intensive and technically-challenging. We developed and performed the first analysis of the Cepheid Xpert MTB/RIF Assay, an integrated hands-free sputum-processing and real-time PCR system with rapid on-demand, near-patient technology, to simultaneously detect M. tuberculosis and rifampin-resistance. Analytic tests of M. tuberculosis DNA demonstrated a limit of detection (LOD) of 4.5 genomes per reaction. Studies using sputum spiked with known numbers of M. tuberculosis colony forming units (cfu) predicted a clinical LOD of 131 cfu/mL. Killing studies showed that the assay's buffer decreased M. tuberculosis viability by at least 8 logs, substantially reducing biohazards. Tests of 23 different commonly-occurring rifampin-resistance mutations demonstrated that all 23 (100%) would be identified as rifampin-resistant. An analysis of 20 non-tuberculosis mycobacteria species confirmed high assay specificity. A small clinical validation study of 107 clinical sputum samples from suspected tuberculosis cases in Vietnam detected 29/29 (100%) smear-positive culture-positive cases, and 22/39 (84.6%) or 38/53 (71.7%) smear-negative culture-positive cases, as determined by growth on solid media or both solid and liquid media, respectively. M. tuberculosis was not detected in 25/25 (100%) of the culture-negative samples. A study of 64 smear-positive culture-positive sputa from retreatment tuberculosis cases in Uganda detected 63/64 (98.4%) culture-positive cases and 9/9 (100%) cases of rifampin-resistance. Rifampin-resistance was excluded in 54/55 (98.2%) susceptible cases. Specificity rose to 100% after correcting for a conventional susceptibility test error. In conclusion, this highly-sensitive and simple-to-use system can detect M. tuberculosis directly from sputum in under two hours. | | Language | ENG | | Pub Type(s) | JOURNAL ARTICLE
| | PubMed ID | 19864480 |
|
|
| |
Advertise on this site.
| | |
|
